title: Letter to the editor of travel medicine and infectious disease.
authors.forename: Martin
authors.initials: M
authors.lastname: Tepper
authors.forename: Steven
authors.initials: S
authors.lastname: Schofield
mesh_terms: D000962:Antimalarials / Q000627:therapeutic use*; D053626:Atovaquone / Q000627:therapeutic use; D018890:Chemoprevention; D004318:Doxycycline / Q000627:therapeutic use; D004338:Drug Combinations; D006801:Humans; D016778:Malaria, Falciparum / Q000517:prevention & control*; D015767:Mefloquine / Q000627:therapeutic use; D002727:Proguanil / Q000627:therapeutic use; D057236:Travel Medicine
chemical_list: D000962:Antimalarials; D004338:Drug Combinations; C109496:atovaquone, proguanil drug combination; D004318:Doxycycline; D002727:Proguanil; D015767:Mefloquine; D053626:Atovaquone